May 2020
On Thursday, May 7, at 1:00 PM, by phone, Chairwoman Carolyn B. Maloney will co-host a call with Rep. Don Beyer, the Vice Chairman of the Joint Economic Committee (JEC), to hear from Nobel Prize-winning economist Joseph Stiglitz. Professor Stiglitz will brief members of the Oversight Committee and JEC on economic priorities as Congress undertakes the next phase of the legislative responses to Coronavirus. On Thursday, May 7, at 1:00 PM, by phone, Chairwoman Carolyn B. Maloney will co-host a call with Rep.
On Thursday, May 7, at 1:00 PM, by phone, Chairwoman Carolyn B. Maloney will co-host a call with Rep. Don Beyer, the Vice Chairman of the Joint Economic Committee (JEC), to hear from Nobel Prize-winning economist Joseph Stiglitz. Professor Stiglitz will brief members of the Oversight Committee and JEC on economic priorities as Congress undertakes the next phase of the legislative responses to Coronavirus. On Thursday, May 7, at 1:00 PM, by phone, Chairwoman Carolyn B. Maloney will co-host a call with Rep.
Washington, D.C. (May 7, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, Rep.
Washington, D.C. (May 6, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued the following statement after the Trump Administration finalized a rule that would weaken protections for student survivors and strip the responsibility of schools to protect students from sexual assault and harassment:
Washington, D.C. (May 4, 2020)—Today, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, issued the following statement after the Food and Drug Administration (FDA) revised its policy on serological antibody testing to address wide gaps in the Trump Administration's handling of serology tests identified in the Subcommittee's investigation:
Washington, D.C. (May 4, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Committee Member Jackie Speier sent a letter to Jaguar Health seeking information about the company's recent decision to increase the price of Mytesi while seeking approval to use the drug for coronavirus patients.
Washington, D.C. (May 4, 2020)—Today, Rep. Stephen F.
WASHINGTON—Congresswoman Katie Porter (CA-45) today introduced legislation to increase accountability for federal agency heads and other officials that have not been vetted by the Senate. Her Accountability for Acting Officials Act would limit who can serve as an "acting" official and for how long, closing various loopholes in the current law. The bill would also ramp up transparency and reporting by acting officials.
WASHINGTON, DC – Today, Chairs of the House Committees that oversee the Department of Health and Human Services (HHS) voiced their strong opposition to a harmful Trump Administration rule that would roll back Affordable Care Act (ACA) nondiscrimination protections. In a letter, House Ways and Means Committee Chairman Richard E.
A "parallel" COVID-19 pandemic may be occurring with "far less scrutiny in another setting housing vulnerable seniors"